BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
World/Source-attributed reporting

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.

Reports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.
ORIGINAL SOURCE

Consumer News and Business Channel

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗